This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Helios Technologies (HLIO) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
HLIONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Stryker's Robotics and Global Gains Offset by Macro Concerns
by Zacks Equity Research
SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.
JNJPositive Net Change MDTPositive Net Change SYKNegative Net Change ZBHNegative Net Change
medical medical-devices
CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes
by Moumi Mondal
CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.
KRPositive Net Change CVSPositive Net Change ELVPositive Net Change
medical medical-devices
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
by Nalak Das
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
BSXPositive Net Change JNJPositive Net Change GEHCNegative Net Change TEMPositive Net Change
medical-devices
Vaso Stock Down Following Q2 Earnings as Revenue and Margins Fall
by Zacks Equity Research
VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.
VASONegative Net Change
earnings medical medical-devices
BIAF Stock Down Following Q2 Earnings Despite CyPath Lung Growth
by Zacks Equity Research
bioAffinity shifts its focus on CyPath Lung as the second-quarter 2025 loss widens, with rising adoption and new market expansion underway.
BIAFNegative Net Change
earnings medical medical-devices
Retractable Technologies Stock Gains Following Q2 Earnings Growth
by Zacks Equity Research
RVP reports stronger second-quarter 2025 sales and narrows losses as domestic output offsets tariff headwinds.
RVPNegative Net Change
earnings medical medical-devices
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
by Zacks Equity Research
MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change MBOTNegative Net Change
medical medical-devices
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
by Zacks Equity Research
ANGO benefits from NanoKnife, clinical milestones, and a balanced portfolio despite tariff headwinds.
BSXPositive Net Change ANGOPositive Net Change WSTNegative Net Change MEDPNegative Net Change
medical medical-devices
Should Quest Diagnostics Stock Be in Your Portfolio Right Now?
by Zacks Equity Research
DGX drives growth with advanced diagnostics, acquisitions and cost savings, but rising debt and macro risks weigh on its outlook.
BSXPositive Net Change DGXNegative Net Change PAHCNegative Net Change NVSTNegative Net Change
medical medical-devices
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
by Zacks Equity Research
ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.
BSXPositive Net Change ALCNegative Net Change MEDPNegative Net Change WGSNegative Net Change
earnings medical medical-devices
Should You Buy Materion (MTRN) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MTRNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Mueller Water Products (MWA)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MWAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Grab These 4 Stocks With Solid Net Profit Margins to Boost Returns
by Anirudha Bhagat
Boost your portfolio with GLDD, INFU, TILE and CENX, each showing strong net profit margins and rising EPS estimates.
GLDDNegative Net Change CENXNegative Net Change TILENegative Net Change INFUNegative Net Change
basic-materials industrial-products medical medical-devices
Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring
by Zacks Equity Research
MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.
BSXPositive Net Change MASINegative Net Change WSTNegative Net Change MEDPNegative Net Change
medical medical-devices
GEHC Positioned for Growth With AI, Global Expansion and Margins
by Zacks Equity Research
GE HealthCare's Q2 results highlight revenue growth, AI-driven innovation, and global expansion with margin gains and strong demand.
ABTNegative Net Change BSXPositive Net Change PHGNegative Net Change GEHCNegative Net Change
medical medical-devices
DexCom Expands Access and Innovation While Balancing Headwinds
by Zacks Equity Research
DXCM grows on type 2 access, Stelo adoption, and new sensor launches, but faces margin pressures, competition and leadership transition.
ABTNegative Net Change RHHBYPositive Net Change MDTPositive Net Change DXCMNegative Net Change
medical medical-devices
Polaris Inc (PII) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PIIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Wex (WEX)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WEXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
by Moumi Mondal
HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.
RHHBYPositive Net Change DGXNegative Net Change HOLXNegative Net Change
medical medical-devices
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
by Zacks Equity Research
NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting severe facial pain, scheduled to launch in late 2025.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change NMTCNegative Net Change
medical medical-devices
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals
by Debanjana Dey
HIMS eyes long-term growth with new hormonal health offerings, international expansion and high GLP-1 retention.
AMWLNegative Net Change HIMSNegative Net Change LFMDNegative Net Change
medical medical-devices
Should You Buy LendingClub (LC) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
LCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Williams-Sonoma (WSM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
WSMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Sally Beauty (SBH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SBHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines